lunedì 21 novembre 2016

Marijuana Sector Remains One of Markets Hottest Industry Behind Newest Products and Services

PALM BEACH, Florida, November 16, 2016 /PRNewswire/ --

The exploding cannabis and legal marijuana industry, globally and within the United States, is calling for a significant expansion and improvement of both services and operations as marijuana stocks within the industry aim to capitalize on the unprecedented momentum. Active companies in the sector this week include: Vemanti Group, Inc. (OTC: VMNT), Medical Marijuana, Inc. (OTC: MJNA), Agritek Holdings, Inc. (OTC: AGTK), Cannabix Technologies Inc. (OTC: BLOZF) and Medical Cannabis Payment Solutions (OTC: REFG).

Vemanti Group, Inc. (OTC PINK: VMNT) a diversified holding corporation, announced today that its preparing to launch a new wholly-owned subsidiary, which will look to provide a comprehensive mobile commerce and payments service for the emerging cannabis industry. Through their smartphones, the service will enable retail customers to pay for goods at any participating dispensary without using physical cash. It will also present dispensaries, growers, and other legitimate participants of the industry with the opportunity of carrying out non-retail transactions among themselves in digital payments. 

Read the full Vemanti (VMNT) Press Release at:

The Company believes that the emerging legal cannabis industry where retail and non-retail transactions, including vendor payments and payroll, are almost exclusively paid for with cash presents a real challenge for financial institutions. Concerned about the evolving conflict between federal and state laws, they are eager to avoid the inherent risks associated with this cash-intensive sector. It is widely acknowledged that many are unwilling to go to the expense of establishing and maintaining the type of thorough due diligence program for this emerging market at the present time in order to comply with growing demands of Know-Your-Customer (KYC) guidelines, anti-money laundering regulations, and the US Patriot Act. As the result, traditional banking and payment solutions have been out of reach for the vast majority of cannabis businesses.

"The cannabis industry needs access to digital payments in order to grow, and consumers want a safe and secure way to purchase marijuana products without always relying on cash. Our goal for the new subsidiary is to launch a service that alleviates the risk of cash transactions and helps dispensaries monitor and record data needed to address concerns about violating anti-money laundering laws, with the long-term goal of moving transactions away from cash altogether. It will comply with every relevant regulatory requirement and provide a sustainable solution for the cannabis industry", commented Tan Tran, CEO of Vemanti Group.

In other cannabis developments and happenings to watch this week in the markets:

StoneBridge Partners, LLC -- a global finance communication and consulting firm -- announces the release of an in-depth business analysis of Medical Marijuana, Inc. (OTC PINK: MJNA) presented in a comprehensive report. The report, which outlines the company's formation and current operations, also offers insight into the perceived opportunities in the explosive-growth market of cannabis. It explores the Company's diversified portfolio of cannabis organizations and brands that continue to flourish as new markets open and existing markets continue to develop

Agritek Holdings, Inc. (OTC: AGTK) closed down slightly on Tuesday on just over 6.88 Million shares traded by the market close. Agritek Holdings, Inc. offers various products and services to the medicinal marijuana sector in the United States. It distributes hemp-based nutritional products; and provides solutions for electronically processing merchant transactions.

Cannabix Technologies Inc. (OTC Pink: BLOZF) closed up over 24% on Tuesday at $0.59 on just under 1 Million shares traded by the market close. Cannabix Technologies, developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, recently released images of its Beta 2.0 Cannabix Marijuana Breathalyzer. New images of the device can be viewed at

Medical Cannabis Payment Solutions (OTC: Pink: REFG) works to solve the fragmentation problem by identifying tools that are important to dispensaries, and customizing those tools specifically catered to the industry. We strive to create awareness within the medicinal marijuana industry and to develop an environmentally friendly, economically sustainable business while increasing shareholder value.

DISCLAIMER: (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated three thousand nine hundred dollars for news coverage of the current press release issued by Vemanti Group, Inc.. by the company. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.

Contact Information:
Media Contact email: - +1-(561)325-8757

Marijuana Sector Remains One of Markets Hottest Industry Behind Newest Products and Services

giovedì 17 novembre 2016

U.S. Patent Allowance Granted to Medical Marijuana, Inc.'s Investment AXIM(R) Biotech for Use of All Cannabinoids in Its Controlled Release Chewing Gum

SAN DIEGO, CA--(Marketwired - November 16, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its major investment AXIM® Biotechnologies, Inc. (AXIM® Biotech(AXIM), a world leader in hemp cannabinoid research and development, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 9,433,601, a patent that claims the use of all cannabinoids in cannabinoid-containing controlled-release chewing gum products. A Notice of Allowance is issued after the USPTO makes a determination that a patent can be granted from the application, filed in April 2015. This patent covers the inclusion of all cannabinoids (both natural and synthetic) in a chewing gum delivery system, including Tetrahydrocannabinol (THC), all of which may be incorporated in the Company's chewing gum products.
This new patent is an extension of AXIM® Biotech's patent for chewing gum as delivery methods for cannabidiol (Chewing Gum Compositions Comprising Cannabinoids). Prior to this new allowance, Patent 9,023,322 only claimed gum products as a delivery mechanism for cannabidiol (CBD), a well-known cannabinoid.
"We congratulate the AXIM team on receiving this new patent, another major milestone in the Company's continued efforts to research new solutions using cannabinoid-based drugs," said Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
"This patent will enable AXIM to include any of the at least 85 different cannabinoid compounds found in the cannabis plant, including CBD and THC, into its multiple cannabinoid controlled-release chewing gum products," added Dr. Titus. "As investors in AXIM, we are enthusiastic about how the Company continues to move forward as a leader in cannabinoid research and development."
AXIM® Biotech developed the patents it now owns for chewing gum as a delivery method for cannabinoids into two separate products. Its CBD-only Canchew® gum is marketed and is legal to purchase wherever CBD hemp oil products are sold. AXIM® Biotech holds the exclusive rights to market and distribute CanChew® Gum globally. CanChew® is a botanical hemp-derived CBD chewing gum with a unique oral mucosal absorbance delivery system. Features listed on the CanChew® website include:
  • Non-habit forming
  • No prescription needed
  • Available in all 50 states
  • Great-tasting mint gum has no artificial sweeteners or preservatives
  • Non-GMO, gluten free, vegan and kosher
In addition, AXIM® will start clinical trials for its combination CBD/THC gum, MedChew® Rx, for the treatment of pain and spasticity associated with multiple sclerosis. Directly compared to a sublingually delivered cannabis-based product currently on the market for MS, the estimated market size for MedChew® Rx is $4.8 billion USD. MedChew® Rx is on track to be fully registered by the EMA and FDA.
AXIM has also developed CanChew Plus™ CBD containing gum with improved delivery system and doses of 10 mg of CBD and 30mg of CBD which is set to begin clinical trials in the EU. Besides these, AXIM has developed CanChew Rx™, which is based on pharmaceutical-grade, 99.9% pure CBD crystals, extracted and manufactured based on company IPs and containing 10, 30, 50, 100 and 150 mg of CBD in microencapsulated form (AXIM IP) for significantly increased bioavailability of the Active Pharmaceutical Ingredient.
Another AXIM® Biotech patent-pending cannabis innovation in clinical trials is AX-1602. The first of its kind, AX-1602 contains CBG (cannabigerol) and other cannabinoids as a treatment for psoriasis and atopic dermatitis.
AXIM® Biotech's core belief is responsibility for environmental stewardship combined with development of innovative products to address conditions with no currently known effective treatment including: Parkinson's disease, Alzheimer's disease/dementiaADHD(attention deficit hyperactivity disorder), PTSD, autism, MS, spasticity, pain, RLS (restless leg syndrome), glaucoma, IBD, IBS and Crohn's disease.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit

U.S. Patent Allowance Granted to Medical Marijuana, Inc.'s Investment AXIM(R) Biotech for Use of All Cannabinoids in Its Controlled Release Chewing Gum

venerdì 4 novembre 2016

Legalizzazione della cannabis, il senatore Della Vedova a Reggio Emilia

Appuntamento alle 17 di domenica 6 al circolo Gardenia in via Regina Elena. Si parlerà della proposta di legge ora in discussione in parlamento e di processi di regolarizzazione vincenti

REGGIO EMILIA - Questa estate a Reggio Emilia sono state raccolte 2.300 firme a supporto della legge popolare "legalizziamo"; lo scorso ottobre è stato approvato un documento in Consiglio comunale a favore della proposta in discussione in parlamento "cannabis legale", supportata da oltre 130 parlamentari.

I fatti dicono che negli ultimi decenni produzione, traffici e consumatori di stupefacenti sono cresciuti a dismisura, divenendo il terzo business più redditizio al mondo dopo cibo ed energia. Solo in Italia, il giro d’affari della narcomafie è stimato intorno ai 30 miliardi euro.

Delle effetto delle droghe non solo sulla nostra società, ma anche sulle democrazie nel mondo se ne parlerà domenica 6 novembre alle 17 al circolo Arci Gardenia, in viale Regina Elena 14: il Circolo Darwin e Canapaio Ducale Parma propongono un incontro aperto di approfondimento sul tema della legalizzazione della cannabis.

Per l'occasione sarà presente il senatore Benedetto Della Vedova, presidente dell’intergruppo Cannabis Legale, che presenterà la proposta di legge ora in discussione in parlamento; insieme a lui ci sarà anche Luca Marola di Canapaio Ducale, che parlerà di processi di legalizzazione vincenti realizzati nel mondo. Modera il dibattito Dario De Lucia, il consigliere comunale Pd che ha fatto approvare il documento a favore della vendita di Stato della marijuana.

Legalizzazione della cannabis, il senatore Della Vedova a Reggio Emilia

lunedì 17 ottobre 2016

Richard Branson to cannabis advocates: Fight to legalize it.

Billionaire and tech entrepreneur tells New West summit attendees marijuana should be decriminalized worldwide.

Renowned billionaire and tech entrepreneur Richard Branson told a room full of cannabis advocates he was simply in the mood to "take a spliff or two," and much of the world is ready to legally take some tokes, too.

"Why not?" the Virgin Group founder asked a crowd of about 1,000 people Saturday during the second annual New West Summit conference, "The Future of Cannabis, Now," in downtown San Francisco.

Speaking via Skype, Branson, an unapologetic cannabis supporter, said he's spent the past five years serving on the Global Commission on Drug Policy along with former United Nations General Secretary Kofi Annan and 15 former world leaders calling not only for the controversial decriminalization of drugs, but also for its legalization worldwide.

"That's the only way of sorting out the problems that come with drugs by not regulating and leaving it up to the underworld to supply drugs," he said. "Our commission has worked really quite hard on that. We've had some successes and some massive failures, we're going to keep going until we get governments to see otherwise."

Read more at: Richard Branson to cannabis advocates: Fight to legalize it.

domenica 18 settembre 2016

Patients may soon be able to use medical marijuana in California hospital

In a first-ever for California, patients at Marin General may soon be allowed to consume medical marijuana in the hospital.
If members of the Marin Healthcare District approve the resolution introduced by Dr. Larry Bedard at Tuesday’s meeting, the hospital’s staff would begin a review process examining the legal and medical implications of using medical pot at the acute-care center.
Patients, however, would not be allowed to smoke the drug, which doctors have been legally prescribing in California since the late 1990s because smoking is banned in the state’s hospitals.
Last month, Bedard told Media News about his plan.
“I want to have Marin General be the first hospital in California to openly and transparently allow patients to use medical cannabis,” said Bedard, a retired emergency medicine physician who used to work at Marin General and is now a member of the district board.
Last year, the pro-marijuana activist group California NORML reported that more than 1,500 physicians in the state had recommended medical marijuana under Prop. 215. The so-called Compassionate Use Act of 1996 effectively legalized the medicinal use of cannabis by seriously ill Californians. A federal court decision later established that California physicians who follow certain guidelines in recommending or approving the medical use of marijuana are immune from sanction or criminal prosecution.
Under the law, physicians are free to recommend marijuana for their patients, so long as they don’t actually assist them in obtaining it.
Bedard is no stranger to the often controversial subject of medical marijuana. He helped author the rebuttal to the argument against Proposition 64, an initiative appearing on the Nov. 8 ballot that would legalize the recreational use of marijuana. If voters pass the measure, California would join a handful of states and cities that already allow the practice, including Alaska, Colorado, Oregon and Washington, as well as Portland and South Portland, Maine, and Keego Harbor, Michigan.
Proposition 64 would make the recreational use of marijuana legal for adults age 21 and older in California; adults would be allowed to grow small amounts at home for personal use. The initiative would limit the sale of non-medical marijuana to be regulated as licensed businesses that only adults 21 and older would be permitted to enter.
Bedard said he is passionate about legalizing marijuana because he believes people of color are suffering disproportionately under existing law.
“Four times as many blacks and Latinos get arrested as whites with virtually the same use rates,” Bedard said. “If you want to reform the justice system, this is by far the easiest and most effective way.”
He also believes that adults should be able to choose whether they want to use cannabis or alcohol, which he considers to be far more harmful.
“As an emergency physician, I know that marijuana is safer than alcohol,” Bedard told Media News.
Bedard served on a California Medical Association task force on marijuana that led to the association recommending the legalization of cannabis.
Last month, after Bedard had sent his resolution to the administrators at Marin General, along with his fellow board members and other interested parties, the reaction was mixed.
“I think it is a fantastic idea,” said Frederick Mayer, a retired Marin pharmacist who heads Pharmacists Planning Services Inc., a nonprofit pharmacy education organization.
Mayer said hospitals in Israel have pioneered the use of cannabis for palliative care. He said in some cases marijuana can be substituted for the more dangerous narcotics used for pain management, which are leading increasingly to addiction problems.
Others, though, are more cautious, a reflection of the public’s mixed feeling about legalizing all uses of pot. District board member Jennifer Rienks said last month that she still has “a lot of questions” about Bedard’s proposal.
“At this point, I really need to hear more about it,” Rienks said.
In his resolution, Bedard acknowledges that Marin General administrators are “concerned that the federal government could/would retaliate by lifting the hospital’s Medicare provider number and the state could withhold Medi-Cal funding.”
But he says such fears are overblown since a federal budget amendment authored by California Reps. Dana Rohrabacher, a Republican and Democrat Sam Farr prevents the government from using federal funds to penalize patients, physicians and hospitals that are complying with state law.

Patients may soon be able to use medical marijuana in California hospital

mercoledì 14 settembre 2016

Degrado e droghe per strada. Cosi' in tutte le citta'. Come farsi meno male

Comunicato di Vincenzo Donvito
5 settembre 2016 14:43

 Non passa giorno che sulle cronache locali -e non- di tutti i media, si parli del degrado urbano, quasi sempre associato allo spaccio di droghe illegali. Immagini di persone che bivaccano, meglio se con una qualche bottiglia in mano e una sigaretta che possa essere scambiata per spinello, e seduti nei luoghi piu' significativi della citta', chiese e piazze storiche, giardini frequentati anche di giorno da bambini, etc. Immagini su cui talvolta i media provvedono ad oscurare i volti delle persone, ma non se queste sono manifestamente con la pelle non-bianca: dando cosi' il loro contributo al discutibile legame, tipico di chi ragiona con la pancia invece che con la testa, tra non-bianco e spacciatore di droga, e quindi responsabile del degrado.
Lasciando ad ogni media la propria responsabilita' nell'alimentare disordine pubblico, cio' che ci preme sottolineare e' che il metodo per cercare di farsi meno male e' a portata di mano, ma sembra che il nostro legislatore non sia interessato. Stiamo parlando della legalizzazione delle droghe, cioe' il controllo del mercato da parte dello Stato per un prodotto che oggi -pur se illegale- e' capillarmente diffuso e consumato si' da rendere libero il suo mercato: le forze dell'ordine non ce la fanno a seguire il ritmo dello spaccio per strada e, nonostante gli ingenti sequestri che vengono operati ogni giorno, la presenza e l'offerta di queste sostanze e' sempre maggiore, soprattutto per strada. Le proposte di legge in Parlamento ci sono, ma sono al momento bloccate nonostante si sia manifestato un ampio schieramento trasversale che le sostiene. In prospettiva si vede solo il buio. E lo spinello, che e' consumato da quasi tutti i giovani e non solo, continua ad essere venduto clandestinamente per strada da spacciatori che -in virtu' di un potenziale loro maggiore guadagno- non esitano a proporre anche l'acquisto di sostanze piu' pericolose e che creano facilmente dipendenza, come eroina, cocaina o metamfetamine varie.
Al momento, nonostante le positive esperienze in merito registrate in diversi Stati europei e degli Usa e delle Americhe, la legalizzazione e' una chimera. E il risultato sono queste immagini e queste quotidianita' di cui dicevamo prima. Certamente il problema non sara' risolto, ma sicuramente sara' contenuto ed arginato, con meno spacciatori e meno clienti per le strade.
Ci viene spontanea una domanda che rivolgiamo ai media, soprattutto locali, che sono giustamente preoccupati del degrado delle citta' per le quali si impegnano a svolgere un servizio di informazione: tante volte avete fatto campagne nell'interesse dei cittadini, promosso petizioni, sostenuto progetti di legge... perche' in questo caso vi limitate solo ad indicare coi volti scoperti non-bianchi i presunti colpevoli e non vi fate partigiani di una politica di riduzione del danno, sulle droghe e sulle nostre citta'?
Degrado e droghe per strada. Cosi' in tutte le citta'. Come farsi meno male

lunedì 12 settembre 2016

ITALIA - Cannabis terapeutica. Caso Pellegrini. Civati: ministro Orlando si lava le mani

"Avevamo chiesto al ministro Orlando di intervenire sul caso Pellegrini promuovendo una riforma del Codice penale che consentisse alle persone affette da patologie che necessitano di cure palliative, come quelle che richiedono l'uso della cannabis e dei suoi derivati, di non dover incorrere in denunce e pene detentive. Pellegrini, lo ricordiamo, affetto da fibromialgia, si trova ora agli arresti domiciliari dopo essere stato in carcere per molti giorni, nonostante le sue condizioni di salute". Lo dichiarano in una nota i deputati di Possibile, Pippo Civati e Andrea Maestri, che aggiungono: "La risposta del ministro Orlando alle nostre richieste si e' dimostrata ancora una volta pilatesca: mentre il Governo non esita a invadere il campo riservato al Parlamento con decreti-legge, leggi delega in bianco e voti di fiducia sui temi piu' vari, sull'autoproduzione e la detenzione di cannabis per uso terapeutico, ancora sanzionato penalmente nel nostro paese, il ministro della Giustizia si limita a ricordare la giurisprudenza piu' favorevole (ci pensi la Magistratura) e a rimettersi alle forze politiche che hanno assunto l'iniziativa parlamentare (ci pensi il Parlamento)". "Una questione- concludono Civati e Maestri- che dovrebbe spingere tutti a riflessioni e azioni di buon senso e' lasciata ancora una volta da questo Governo nell'ambiguita', senza coraggio e nell'ignoranza totale delle leggi e delle procedure". 

ITALIA - Cannabis terapeutica. Caso Pellegrini. Civati: ministro Orlando si lava le mani